![]() |
![]() |
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
(51) | INT.CL. | A61K 39/12 | (2006.01) |
A61K2039/545 | (2013.01) | ||
A61P 31/14 | (2006.01) | ||
A61K2039/55 | (2013.01) | ||
C12N2760/18634 | (2013.01) | ||
A61K 39/12 | (2013.01) | ||
A61P 31/14 | (2018.01) | ||
A61K 39/155 | (2013.01) | ||
A61K2039/53 | (2013.01) | ||
A61K2039/55505 | (2013.01) | ||
A61K2039/55555 | (2013.01) | ||
A61K2039/55566 | (2013.01) | ||
A61K2039/575 | (2013.01) | ||
C12N2760/18534 | (2013.01) | ||
C12N2760/18571 | (2013.01) |
(11) | Patento numeris | 4144368 |
(13) | Dokumento rūšis | T |
(96) | Europos patento paraiškos numeris | 22180831.4 |
Europos patento paraiškos padavimo data | 2012-01-26 | |
(97) | Europos patento paraiškos paskelbimo data | 2023-03-08 |
(45) | Paskelbimo apie Europos patento išdavimą data | 2025-02-26 |
(46) | Apibrėžties vertimo paskelbimo data |
(30) | Numeris | Data | Šalis |
201161436355 P | 2011-01-26 | US |
(72) |
DORMITZER, Philip, R. , US
|
(73) |
GlaxoSmithKline Biologicals S.A. ,
Rue de l'Institut, 89, 1330 Rixensart,
BE
|
(54) | RSV IMMUNIZATION REGIMEN |
RSV IMMUNIZATION REGIMEN |